THE group of conditions loosely termed retinal venous occlusions present many interesting problems with regard to pathogenesis, natural history, and treatment. The present investigation was undertaken with the objectives of collecting a series of these patients and studying the natural history and possible effects of treatment with the drug Atromid S.
Clinical Findings
Age.-Range 39 to 81 years, the majority of patients being in the 7th and 8th decades. 
Effect of Treatment with Atromid S
We adopted the criterion of Cullen, Ireland, and Oliver (1964) 
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Atromid does not, therefore, appear to influence the prognosis. One patient developed a recurrence of thrombosis in the other eye while on treatment with the drug. There were two cases of thrombotic glaucoma both of which had the placebo.
Applanation Pressure Readings There were sixteen patients with complete or incomplete central vein occlusion. Of these, five had applanation readings above 21 mm. Hg, and two of them developed thrombotic glaucoma. By contrast, of 27 patients with tributary vein occlusion, only two had an applanation pressure above 21 mm. Hg.
Ophthalmodynamometry
Systolic ophthalmodynamometry readings were taken in all 43 patients. We found that in six patients there was a fall in at least 15 per cent. in the dynamometry reading in the affected eye. Vernon Smith (Paton, Rubinstein, and Smith, 1964) found that the systolic dynamometry reading was reduced in 30 per cent. of his patients.
Serum Proteins A total of nine patients out of the 43 had abnormal serum proteins, the values being those seen in less than 5 per cent. of the population. In all, seventeen separate abnormal components were found. The x2 globulin was raised in seven cases, 3 globulins in five, and y globulins in five. There were no abnormalities in albumin or in al globulin. Three patients were highly abnormal, in that they each had raised a2, ,B, and y globulins. These data show eyes with occlusions in the lower half do much worse than those with occlusions in the upper half. Discussion Natural History.-In studying the natural history of central vein occlusion, one has to bear in mind the probable pathogenesis of the condition. Recent work has shown that these conditions are not simply venous occlusions but are probably due to the combined effect of arterial insufficiency and venous occlusion. Hayreh (1965) showed that, to produce central vein occlusion experimentally, it is necessary to occlude both the central artery and the vein. In a symposium held in 1964, Rubinstein demonstrated the passage of fluorescein through the supposedly occluded segment of the vein, Vernon Smith showed that low ophthalmodynamometric readings often occur in the affected eye, and Paton showed that these patients often have arterial insufficiency elsewhere in the body.
Effect of Age on Visual Prognosis
We frequently noted narrowing and sheathing of arterial segments, which often became evident later when the haemorrhages were absorbed. Some of our patients showed ophthalmodynamometric evidence of arterial insufficiency and arterial insufficiency was commonly found elsewhere.
There have been few studies of the natural history of the disease. Lister and Zwink (1953) studied 25 cases and demonstrated that there was an extraordinary variety of end-results. They also stated that initial visual acuity is a guide to final visual acuity. We found this to be true for some cases only.
The natural history appears different according to the type of occlusion. In 16 cases of central occlusion the visual acuity and fundus picture were classed as follows: There is a frequent association of this condition with chronic simple glaucoma, and five of our sixteen cases had applanation readings above the normal.
Prognosis.-Most occlusions in the lower hemisphere occurred at the disc, and were infero-temporal in distribution. Without exception these all did very badly. Clinically, the initial visual acuity was poor, but even if a good initial acuity was found, this frequently fell. While most cases of superior temporal occlusion cleared in 7 to 8 months, the infero-temporal occlusions had not cleared even after the full year of the trial (Figure) . The fall in visual acuity appeared to be due to macular oedema, which often went on to cystic degenerative changes with a circinate ring of exudates around the macula. In general, poor final visual acuity was frequently associated with a cystic change at the macula; such cystic changes occurred in five of our 43 cases. Treatment.-At the start of the trial the question had to be faced whether it was justifiable to deny any treatment to the 50 per cent. of patients who would receive only the placebo. We are not, however, aware of any treatment of proven value in this condition. Lister (1964) said he was not convinced that anticoagulants were of any use, although Vannas and Orma (1957) claimed that they had a favourable effect.
The pharmacological and clinical indications for Atromid therapy were discussed by Oliver (1964) . The drug lowers the serum cholesterol and is said to affect platelet stickiness and to have a fibrinolytic action (Carson, McDonald, Pickard, Pilkington, Davies, and Love, 1963) . The exact part played by thrombus formation in these conditions is not fully understood, but it is reasonable to suppose that a drug with the reputed actions of Atromid S might benefit these patients. Unfortunately, as our results show, the use of Atromid S does not materially affect the outcome, although it is valuable in cases of diabetic retinopathy (Cullen and others, 1964) . The finding that it reduces the lipid exudates in the diabetic retina is interesting because these exudates are also found in branch vein occlusions. We have often noted such exudates in the later stages of retinal vein occlusion of the disease, but Atromid therapy did not appear to prevent their formation.
The finding of abnormal serum proteins deserves further study. Macroglobulinaemia is known to be associated with central retinal vein occlusion, but was found in none of our patients. Nevertheless, serum protein abnormality may be involved in the pathogenesis of the condition.
Summary
(1) Treatment with Atromid S does not appear to affect the outcome of retinal vascular occlusions.
(2) Age and sex do not appear to affect the prognosis in vascular occlusion. 
